Home / Article

AAA Biotech Expands Recombinant Proteins Portfolio to Advance Life Sciences Research

Burstable News - Business and Technology News August 12, 2025
By Burstable News Staff
Read Original Article →
AAA Biotech Expands Recombinant Proteins Portfolio to Advance Life Sciences Research

Summary

AAA Biotech enhances its recombinant proteins portfolio, offering high-quality research reagents to support groundbreaking life sciences research.

Full Article

AAA Biotech has announced the expansion of its recombinant proteins (rProteins) portfolio, reinforcing its position as a global leader in providing high-quality research reagents for the life sciences sector. This development is set to significantly impact biomedical research by offering scientists and researchers access to a broader range of tools for their experiments.

The company's recombinant proteins are engineered through precise genetic methods, with target genes expressed in active systems such as E. coli, mammalian cells (HEK293, CHO), yeast, and insect cells. These proteins are crucial for a wide array of applications, including protein-protein and protein-DNA interactions, functional biological assays, and drug discovery processes. AAA Biotech ensures the highest standards of quality, with purities typically exceeding 95%, validated through affinity chromatography procedures.

Key features of AAA Biotech's rProteins include high purity and activity, with the majority of proteins guaranteed to be 95% pure and tested for bioactivity. The proteins can be expressed in various systems to accommodate different research needs, including folding, post-translational modifications, and functionality. Additionally, the company offers flexibility in custom expressions and tags, catering to the specific requirements of diverse experiments.

Quality control is a paramount concern for AAA Biotech, with products undergoing rigorous testing and analysis, including SDS-PAGE, endotoxin testing, and activity assays. Each batch comes with a Certificate of Analysis, ensuring researchers have all the necessary documentation for their work. The proteins are available in user-friendly formats, such as lyophilized or ready-to-use liquid forms, facilitating easy storage and handling.

This expansion of AAA Biotech's recombinant proteins portfolio is a testament to the company's commitment to supporting the life sciences community. By providing high-quality, versatile research reagents, AAA Biotech is enabling researchers to push the boundaries of scientific discovery. For more information, visit https://www.aaabiotech.com/.

QR Code for Content Provenance

This story is based on an article that was registered on the blockchain. The original source content used for this article is located at 24-7 Press Release

Article Control ID: 142960